Literature DB >> 21123448

Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid.

Roberta Malaguarnera1, Francesco Frasca, Aldo Garozzo, Fiorenza Gianì, Giuseppe Pandini, Veronica Vella, Riccardo Vigneri, Antonino Belfiore.   

Abstract

CONTEXT: Factors involved in the biology of normal and cancer stem/precursor cells from the thyroid are unknown. Thyroid cancer cells are responsive to insulin and IGF-I and IGF-II and often overexpress the insulin receptor (IR) and the IGF-I receptor (IGF-IR).
OBJECTIVE: We investigated the role of IR isoforms (IR-A and IR-B), IGF-IR, and their ligands in thyroid follicular cell precursors both normal and malignant.
DESIGN: We established cultures of follicular cell precursors as thyrospheres from three papillary thyroid cancers and the corresponding nonaffected tissues. The expression of IR, IGF-IR, and their ligands was evaluated by quantitative RT-PCR and, in one case, also by Western blot. The effects of insulin and IGFs on thyrosphere growth and self-renewal were evaluated.
RESULTS: Thyrospheres were characterized by the expression of stem cell markers and low/absent thyroid specific markers. Thyrospheres from normal tissue, but not from cancer tissue, could be induced to differentiate. Both IR isoforms, IGF-IR, IGF-I and IGF-II, were expressed at high levels in thyrospheres and markedly decreased in differentiating cells. IR-A was the predominant isoform in thyrospheres, especially from cancer, while IR-B was predominant in differentiating cells. Cancer thyrosphere growth was stimulated by insulin and IGFs.
CONCLUSIONS: Our data suggest that IR isoforms and IGF-IR play a role in the biology of follicular thyroid precursors. Cell differentiation is associated with marked changes in the expression of these receptors and cognate ligands. These data may provide insight for future differentiation therapies in thyroid cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21123448     DOI: 10.1210/jc.2010-1255

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  65 in total

1.  Aldehyde dehydrogenase activity plays no functional role in stem cell-like properties in anaplastic thyroid cancer cell lines.

Authors:  Mika Shimamura; Tomomi Kurashige; Norisato Mitsutake; Yuji Nagayama
Journal:  Endocrine       Date:  2016-12-31       Impact factor: 3.633

2.  Insulin receptor isoform switching in intestinal stem cells, progenitors, differentiated lineages and tumors: evidence that IR-B limits proliferation.

Authors:  Sarah F Andres; James G Simmons; Amanda T Mah; M Agostina Santoro; Laurianne Van Landeghem; P Kay Lund
Journal:  J Cell Sci       Date:  2013-10-14       Impact factor: 5.285

Review 3.  Stem cells and cancer stem-like cells in endocrine tissues.

Authors:  Ricardo V Lloyd; Heather Hardin; Celina Montemayor-Garcia; Fabio Rotondo; Luis V Syro; Eva Horvath; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2013-03       Impact factor: 3.943

Review 4.  Recent insights into the cell biology of thyroid angiofollicular units.

Authors:  Ides M Colin; Jean-François Denef; Benoit Lengelé; Marie-Christine Many; Anne-Catherine Gérard
Journal:  Endocr Rev       Date:  2013-01-24       Impact factor: 19.871

Review 5.  Normal vs cancer thyroid stem cells: the road to transformation.

Authors:  M Zane; E Scavo; V Catalano; M Bonanno; M Todaro; R De Maria; G Stassi
Journal:  Oncogene       Date:  2015-05-11       Impact factor: 9.867

6.  Thyroid Abnormalities in Patients With Extreme Insulin Resistance Syndromes.

Authors:  Yevgeniya S Kushchayeva; Sergiy V Kushchayev; Megan Startzell; Elaine Cochran; Sungyoung Auh; Yuhai Dai; Marissa Lightbourne; Monica Skarulis; Rebecca J Brown
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

Review 7.  Novel treatments for anaplastic thyroid carcinoma.

Authors:  Silvia Martina Ferrari; Giusy Elia; Francesca Ragusa; Ilaria Ruffilli; Concettina La Motta; Sabrina Rosaria Paparo; Armando Patrizio; Roberto Vita; Salvatore Benvenga; Gabriele Materazzi; Poupak Fallahi; Alessandro Antonelli
Journal:  Gland Surg       Date:  2020-01

Review 8.  Insulin and IGFs in obesity-related breast cancer.

Authors:  Valentina Belardi; Emily J Gallagher; Ruslan Novosyadlyy; Derek LeRoith
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-10-24       Impact factor: 2.673

9.  Quantifying insulin receptor isoform expression in FFPE breast tumors.

Authors:  Sean C Harrington; S John Weroha; Carol Reynolds; Vera J Suman; Wilma L Lingle; Paul Haluska
Journal:  Growth Horm IGF Res       Date:  2012-04-30       Impact factor: 2.372

10.  Cancer stem cells as a potential therapeutic target in thyroid carcinoma.

Authors:  Luisa Vicari; Cristina Colarossi; Dario Giuffrida; Ruggero De Maria; Lorenzo Memeo
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.